Injective Surges 17-18% on Solana Launch and ETF Progress
Injective (INJ) has seen a significant surge in price, increasing by 17-18% over the past 24 hours. The primary catalyst behind this rise is the native launch of INJ on Solana via Sunrise, which includes extensive DeFi integrations.
The launch eliminates the need for cross-chain bridging and positions INJ as a multi-ecosystem base asset. Multiple accounts have confirmed that 'INJ is now officially live on Solana' as a canonical SPL token, with the address 1NJMqVM4PadjuzYmeB7zV7q7DV8oB3ExaQCd9x6KsLz.
The expansion provides INJ with more trading venues, pairs, and easier access for Solana users. This has driven short-term re-pricing and contributed to the price increase.